Influence of Residualizing Properties of the Radiolabel on Radionuclide Molecular Imaging of HER3 Using Affibody Molecules

Influence of Residualizing Properties of the Radiolabel on Radionuclide Molecular Imaging of HER3 Using Affibody Molecules

Human epidermal growth factor receptor type 3 (HER3) is an emerging therapeutic target in several malignancies. To select potential responders to HER3-targeted therapy, radionuclide molecular imaging of HER3 expression using affibody molecules could be performed. Due to physiological expression of H...

Full description

Bibliographic Details
Main Authors:	Sara S. Rinne, Tianqi Xu, Charles Dahlsson Leitao, Stefan Ståhl, John Löfblom, Anna Orlova, Vladimir Tolmachev, Anzhelika Vorobyeva
Format:	Article
Language:	English
Published:	MDPI AG 2020-02-01
Series:	International Journal of Molecular Sciences
Subjects:	her3 affibody radionuclide molecular imaging iodine pib
Online Access:	https://www.mdpi.com/1422-0067/21/4/1312

Similar Items

Influence of Molecular Design on the Targeting Properties of ABD-Fused Mono- and Bi-Valent Anti-HER3 Affibody Therapeutic Constructs
by: Mohamed Altai, et al.
Published: (2018-10-01)

Molecular Design of HER3-Targeting Affibody Molecules: Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of 68Ga-Labeled Tracers
by: Charles Dahlsson Leitao, et al.
Published: (2019-03-01)

Tumour Targeting using Radiolabelled Affibody Molecules : Influence of Labelling Chemistry
by: Altai, Mohamed
Published: (2014)

Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules
by: Sara S. Rinne, et al.
Published: (2020-03-01)

Development of Affibody molecules for radionuclide molecular imaging and therapy of cancer
by: Honarvar, Hadis
Published: (2016)

Comparative Evaluation of Novel <sup>177</sup>Lu-Labeled PNA Probes for Affibody-Mediated PNA-Based Pretargeting
by: Hanna Tano, et al.
Published: (2021-01-01)

Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1
by: Anzhelika Vorobyeva, et al.
Published: (2020-05-01)

On the Design of Affibody Molecules for Radiolabeling and In Vivo Molecular Imaging
by: Rosik, Daniel
Published: (2013)

Design and Evaluation of Radiolabeled Affibody Tracers for Imaging of HER2-expressing Tumors
by: Wållberg, Helena
Published: (2011)

Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model
by: Charles Dahlsson Leitao, et al.
Published: (2020-06-01)

Preclinical Evaluation of <sup>99m</sup>Tc-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake
by: Maryam Oroujeni, et al.
Published: (2021-03-01)

Affibody Molecules as Targeting Vectors for PET Imaging
by: Vladimir Tolmachev, et al.
Published: (2020-03-01)

Engineering of Affibody molecules for Radionuclide Molecular Imaging and Intracellular Targeting
by: Hofström, Camilla
Published: (2013)

Radiolabeled HER-2 Binding Affibody Molecules for Tumor Targeting : Preclinical Studies
by: Steffen, Ann-Charlott
Published: (2006)

Cellular Studies of HER-family Specific Affibody Molecules
by: Göstring, Lovisa
Published: (2011)

Indirect Radioiodination of DARPin G3 Using N-succinimidyl-<i>Para</i>-Iodobenzoate Improves the Contrast of HER2 Molecular Imaging
by: Anzhelika Vorobyeva, et al.
Published: (2019-06-01)

Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1
by: Anzhelika Vorobyeva, et al.
Published: (2020-10-01)

Affibody-Derived Drug Conjugates Targeting HER2: Effect of Drug Load on Cytotoxicity and Biodistribution
by: Haozhong Ding, et al.
Published: (2021-03-01)

Designing, docking and heterologous expression of an anti-HER2 affibody molecule
by: N. Salmanian Tabasi, et al.
Published: (2018-02-01)

Influence of Several Compounds and Drugs on the Renal Uptake of Radiolabeled Affibody Molecules
by: Javad Garousi, et al.
Published: (2020-06-01)

Incorporation of a Hydrophilic Spacer Reduces Hepatic Uptake of HER2-Targeting Affibody–DM1 Drug Conjugates
by: Haozhong Ding, et al.
Published: (2019-08-01)

Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse Model
by: Tianqi Xu, et al.
Published: (2021-12-01)

Rening av bi- och multispecifika cancer-terapeutiska affinitets-proteiner och c-terminalt modifierade anti-HER3 affibodies för avbildningsdiagnostik
by: Dahlsson Leitao, Charles
Published: (2016)

EGFR- and HER2-Binding Affibody Molecules : Cellular studies of monomeric, dimeric and bispecific ligands
by: Ekerljung, Lina
Published: (2011)

Affibody Molecules for PET Imaging
by: Strand, Joanna
Published: (2015)

Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer
by: Ali Alhuseinalkhudhur, et al.
Published: (2020-03-01)

Comparative Preclinical Evaluation of HER2-Targeting ABD-Fused Affibody<sup>®</sup> Molecules <sup>177</sup>Lu-ABY-271 and <sup>177</sup>Lu-ABY-027: Impact of DOTA Position on ABD Domain
by: Yongsheng Liu, et al.
Published: (2021-06-01)

Development of an Affibody-based Prodrug Against HER2 for Cancer Therapy
by: Westerberg, Cornelia
Published: (2021)

Purification and In Vitro Evaluation of an Anti-HER2 Affibody-Monomethyl Auristatin E Conjugate in HER2-Positive Cancer Cells
by: Isabella Damiani, et al.
Published: (2021-08-01)

Molecular Radionuclide Imaging Using Site-specifically Labelled Recombinant Affibody Molecules : Preparation and Preclinical Evaluation
by: Ahlgren, Sara
Published: (2010)

PLGA Nanoparticles Decorated with Anti-HER2 Affibody for Targeted Delivery and Photoinduced Cell Death
by: Victoria Olegovna Shipunova, et al.
Published: (2021-06-01)

Affibody molecules targeting HER3 for cancer therapy
by: Bass, Tarek
Published: (2017)

PEG Linker Improves Antitumor Efficacy and Safety of Affibody-Based Drug Conjugates
by: Qiyu Li, et al.
Published: (2021-02-01)

Preclinical Evaluation of [68Ga]Ga-DFO-ZEGFR:2377: A Promising Affibody-Based Probe for Noninvasive PET Imaging of EGFR Expression in Tumors
by: Maryam Oroujeni, et al.
Published: (2018-09-01)

Enhancing Antitumor Efficacy of Nucleoside Analog 5-Fluorodeoxyuridine on HER2-Overexpressing Breast Cancer by Affibody-Engineered DNA Nanoparticle
by: Zhang C, et al.
Published: (2020-02-01)

Dimeric Her2-specific affibody mediated cisplatin-loaded nanoparticles for tumor enhanced chemo-radiotherapy
by: Haijun Wang, et al.
Published: (2021-05-01)

Design and In Vitro Evaluation of a Cytotoxic Conjugate Based on the Anti-HER2 Affibody Fused to the Fc Fragment of IgG1
by: Alicja M. Sochaj-Gregorczyk, et al.
Published: (2017-08-01)

PNA-mediated Affibody pretargeting
by: Tano, Hanna
Published: (2017)

EGFR and HER2 Targeting for Radionuclide-Based Imaging and Therapy : Preclinical Studies
by: Nordberg, Erika
Published: (2008)

Possibilities of radionuclide diagnostics of Her2-positive breast cancer using technetium-99m-labeled target molecules: the first experience of clinical use
by: O. D. Bragina, et al.
Published: (2021-04-01)